NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-026-68680-1
Affiliations:
14
Authors:
39
Go to article
Institutions Authors Share
BioNTech US, United States of America (USA)
25.000000
25.000000
25.000000
 0.64
Netherlands Cancer Institute (NKI), Netherlands
12.500000
12.500000
 0.32
BioNTech, Germany
1.000000
 0.03
Oncode Institute, Netherlands
0.500000
 0.01
Interested in Oncology and Carcinogenesis?